HOFFMANN EITLE welcomes new partner to the London office

뉴스 | 02.12.2024

We are pleased to announce that Juliet Redhouse has joined HOFFMANN EITLE as a partner in the biotechnology practice group and will be based in the London office.

Juliet brings over 13 years of experience in patent law, with a particular focus on biotechnology, immunotherapy and molecular diagnostics. Recognised as a leading attorney in Legal500 and IAM 1000 over the last few years, Juliet has earned a strong reputation for her expertise in drafting and managing international patent portfolios. She is also highly experienced in opposition and appeal proceedings at the European Patent Office (EPO), where she has achieved a high success rate in both defending and opposing patents.  Juliet comes recommended for “being an extremely effective counsel in high-stakes opposition and appeal proceedings at the EPO. She is highly strategic, thoughtful and easily integrates into the client’s team.” 

"We are excited to welcome Juliet to our team," said David Miller, partner in the biotechnology team at HOFFMANN EITLE. "Her reputation for excellence and her forward-thinking approach are exactly what we value at Hoffmann Eitle and align perfectly with our commitment to delivering an outstanding service to our clients." 

HOFFMANN EITLE is a leading provider of patent prosecution and litigation services. The addition of Juliet as a partner in the London office further enhances the firm's capabilities in the biotechnology sector and underscores the firm's commitment to expanding its presence in the region.

 

back